Everything you need to know about TMS for Chronic Pain: Emerging Applications Beyond Depression — how it works, what it costs, and how to find a provider who actually knows what they're doing.
TMS vs. Medication: A Side-by-Side Guide
Free PDF — compare effectiveness, side effects, cost, and timelines so you can choose with confidence.
While TMS is best known as a treatment for depression, its applications extend into one of medicine’s most challenging frontiers: chronic pain. Over the past decade, researchers have studied whether targeted TMS can reduce pain in conditions ranging from fibromyalgia to neuropathic pain to chronic migraine. Here’s what the current evidence shows, and where it is limited.
What You’ll Learn
- How motor cortex (M1) TMS modulates pain perception through descending pain pathways
- FDA clearance for single-pulse TMS devices for migraine with aura
- What research shows for fibromyalgia and neuropathic pain, and how strong that evidence is
- Key differences between pain TMS and depression TMS protocols
- Why insurance coverage for pain TMS remains limited compared to depression
How TMS Affects Pain Perception
Pain perception isn’t just a peripheral phenomenon — it involves extensive central processing in the brain. The primary target for pain-related TMS is the motor cortex (M1), located in the central region of the brain. When stimulated, M1 sends signals that modulate the brain’s pain-processing networks — essentially turning down the volume on pain signals coming from the body.
This mechanism explains why TMS for pain targets a different brain region than TMS for depression (which targets the DLPFC). For pain, the treatment coil is placed over the motor cortex, and stimulation protocols are calibrated to produce analgesia without motor effects.
Additionally, TMS applied to the dorsolateral prefrontal cortex (DLPFC) can reduce the emotional suffering component of chronic pain — addressing the depression and anxiety that typically accompany persistent pain conditions.
FDA-Cleared Pain Applications
Migraine with Aura
The FDA first cleared a single-pulse TMS device for acute treatment of migraine with aura in 2013 (De Novo), with the eNeura SpringTMS (sTMS) device following in 2014. It is a prescription device applied at the onset of the aura. In the pivotal sham-controlled trial of about 200 patients, roughly 38% of patients were pain-free at 2 hours versus about 17% with sham.
This is an at-home device — patients can self-administer treatment during a migraine attack, making it an option for those who can’t take or don’t tolerate migraine medications.
Off-Label Applications: What the Research Shows
Fibromyalgia
Fibromyalgia — characterized by widespread pain, fatigue, and cognitive difficulties — involves dysregulation of the brain’s pain processing systems. Several randomized trials have evaluated TMS for fibromyalgia:
Trial results in fibromyalgia have been mixed. High-frequency motor cortex stimulation and DLPFC stimulation are the most studied targets, and several small randomized trials and meta-analyses report short-term pain reductions versus sham, but trials are small, protocols vary, and the benefit is often modest and temporary. TMS for fibromyalgia is off-label and not an established standard of care.
Neuropathic Pain
Chronic neuropathic pain from conditions like diabetic neuropathy, post-herpetic neuralgia, or failed back surgery has historically been among the most difficult pain conditions to treat. TMS offers a non-pharmacological option:
- Reviews of motor cortex TMS for neuropathic pain generally describe a modest short-term reduction in pain compared with sham, with low-to-moderate certainty evidence, and effects that fade without repeated sessions
- Response varies widely between patients and studies, so no single response rate can be promised
- Because effects are temporary, maintenance sessions are often used, though optimal schedules are not established
Chronic Headache Disorders
Beyond migraine, TMS has been studied for:
- Chronic tension-type headache, post-traumatic headache, and cluster headache: only small studies and case reports; evidence is preliminary
What Patients Should Know
Treatment Protocols Are Different
Pain TMS is not the same as depression TMS. Key differences:
- Target: Usually the motor cortex rather than the DLPFC
- Sessions: Protocols vary; research courses are often around 10 or more sessions over a few weeks
- Maintenance: Effects are temporary, so repeat sessions are often needed
Insurance Coverage Remains Limited
Unlike TMS for depression, which Medicare and many commercial insurers cover when criteria are met, TMS for chronic pain is generally not covered because it is off-label. Ask the clinic about self-pay costs up front. The single-pulse migraine device is a separate prescription product with its own coverage and pricing.
It May Take Several Providers to Find TMS for Pain
Not all TMS clinics offer pain applications — many only treat depression. Finding a provider experienced in motor cortex TMS for pain requires some research. TMS List’s directory allows filtering by conditions treated; our clinic listings include providers offering pain-focused TMS.
The Bottom Line
TMS is no longer just a depression treatment. For patients with chronic pain who have exhausted medication options, motor cortex and DLPFC TMS may offer modest, temporary, non-pharmacological pain relief for some people, though the evidence is limited and use is off-label. The best-supported pain application is the FDA-cleared single-pulse device for acute migraine with aura. Talk with a pain or headache specialist about how TMS would fit alongside physical therapy, cognitive behavioral therapy, and medication management.
Frequently Asked Questions
Is TMS FDA-cleared for chronic pain conditions?
Single-pulse TMS devices (such as eNeura's sTMS) are FDA-cleared for acute treatment of migraine with aura. For other pain conditions like fibromyalgia and neuropathic pain, TMS is used off-label; trials have shown modest short-term benefits but evidence is limited, and insurance coverage is generally not available.
What is the difference between TMS for pain vs. depression?
Pain TMS targets the motor cortex (M1) rather than the DLPFC used for depression. The coil is placed over the central region of the brain rather than behind the forehead. Protocols vary by clinic and study. Some patients receive DLPFC TMS simultaneously to address the emotional suffering component of chronic pain.
How long do pain relief effects from TMS last?
Studies generally report that pain relief from TMS is temporary, lasting from days to a few weeks after a course, and varies by condition and person. Because effects fade, repeat or [maintenance sessions](/blog/maintenance-tms-guide/) are often used, though optimal schedules are not established.
Ready to Explore Your TMS Options?
Browse verified TMS providers, read real reviews, and find the right treatment for your situation.
